We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

22 hedge funds and large institutions have $4.27M invested in ImmuCell in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

0.05% more ownership

Funds ownership: 14.7% → 14.74% (+0.05%)

21% less funds holding

Funds holding: 28 → 22 (-6)

23% less capital invested

Capital invested by funds: $5.56M → $4.27M (-$1.29M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
22
Holders Change
-6
Holders Change %
-21.43%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
8
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cresset Asset Management
Illinois
+$221K
2
Renaissance Technologies
Renaissance Technologies
New York
+$92.9K
3
UBS Group
UBS Group
Switzerland
+$51.6K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$25.7K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.74K

Top Sellers

Rank Fund Capital Flow
1
OMC
Overbrook Management Corp
New York
-$159K
2
Citadel Advisors
Citadel Advisors
Florida
-$115K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$101K
4
WE
Wealth Effects
Massachusetts
-$62.6K
5
Morgan Stanley
Morgan Stanley
New York
-$12.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cresset Asset Management
Illinois
$958K +$221K +56,790 +27%
Vanguard Group
2
Vanguard Group
Pennsylvania
$819K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$543K +$92.9K +23,900 +19%
BL
4
Bleichroeder LP
New York
$369K – – –
SRC
5
Shufro Rose & Co
New York
$303K – – –
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$264K +$25.7K +6,613 +10%
Morgan Stanley
7
Morgan Stanley
New York
$231K -$12.8K -3,300 -5%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$206K +$3.74K +962 +2%
SFS
9
Strategic Financial Services
New York
$113K – – –
Northern Trust
10
Northern Trust
Illinois
$107K +$3.23K +831 +3%
HighTower Advisors
11
HighTower Advisors
Illinois
$77K – – –
PP
12
Prosperity Planning
Missouri
$58.1K – – –
UBS Group
13
UBS Group
Switzerland
$57.9K +$51.6K +13,267 +496%
BlackRock
14
BlackRock
New York
$52K +$2.13K +548 +4%
MFIM
15
Mesirow Financial Investment Management
Illinois
$44.2K – – –
EFS
16
Essex Financial Services
Connecticut
$39.7K – – –
HPC
17
HM Payson & Co
Maine
$14.5K -$7.78K -2,000 -33%
Bank of America
18
Bank of America
North Carolina
$7.54K +$4 +1 +0%
TRCT
19
Tower Research Capital (TRC)
New York
$4.05K -$2.53K -651 -37%
Jones Financial Companies
20
Jones Financial Companies
Missouri
$67 – – –
JP Morgan Chase
21
JP Morgan Chase
New York
$40 -$8 -2 -15%
Wells Fargo
22
Wells Fargo
California
$3 – – –
OMC
23
Overbrook Management Corp
New York
– -$159K -32,857 Closed
Citadel Advisors
24
Citadel Advisors
Florida
– -$115K -23,746 Closed
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
– -$101K -20,844 Closed
1
2

ICCC Hedge Fund Activity: Q3 2024 in Review

22 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2024, worth a combined $4.27M — down 23% from $5.56M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ICCC and 0 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 8 added.

The largest buyer was Cresset Asset Management, adding an estimated $221K. The largest seller was Overbrook Management Corp, exiting entirely with an estimated $159K sold.

  • 22 institutional investors held ImmuCell (ICCC) as of Q3 2024, down from 28 in Q2 2024.
  • Funds reported $4.27M of ImmuCell stock for Q3 2024, down 23% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q3 2024 and 6 closed out, a net change of -6 holders.
  • The largest ImmuCell buyer in Q3 2024 was Cresset Asset Management, an estimated $221K added.
  • The largest ImmuCell seller in Q3 2024 was Overbrook Management Corp, an estimated $159K sold.

Based on aggregated 13F filings for Q3 2024.